✦ LIBER ✦

Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients

✍ Scribed by S. Cho; J-H. Hahm; Y-S. Hong

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 339 KB
Volume: 144
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.2001.04142.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis and p53, Bcl-2 and bax gene ex

Apoptosis and p53, Bcl-2 and bax gene expression in parathyroid glands of patients with hyperparathyroidism

✍ Béla Szende; Parvaneh Farid; Gyula Végső; Ferenc Perner; László Kopper 📂 Article 📅 2004 🏛 Springer Netherlands 🌐 English ⚖ 767 KB

The prognostic value of spontaneous apop

The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue

✍ Xin Xie; Ole Petter F. Clausen; Paula De Angelis; Morten Boysen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

BACKGROUND. Bax, Bcl-2, and p53 proteins are involved in the regulation of apoptosis and have been reported to correlate with prognosis in several tumor types. ## METHODS. Bax, Bcl-2, p53, and the level of spontaneous apoptosis were evaluated in formalin fixed, paraffin embedded pretreatment speci

Prognostic significance of bcl-2, bax, a

Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma

✍ Sang Kyun Sohn; Jin Tae Jung; Dong Hwan Kim; Jong Gwang Kim; Eun Kyung Kwak; Tae 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

Superficial radiotherapy for patients wi

Superficial radiotherapy for patients with basal cell carcinoma : Recurrence rates, histologic subtypes, and expression of p53 and Bcl-2

✍ Beate Zagrodnik; Werner Kempf; Burkhardt Seifert; Beatrix Müller; Günter Burg; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract ## BACKGROUND The histologic subtype of a basal cell carcinoma (BCC) may be an important factor for the success of a certain treatment modality. In the current article, the authors report recurrence rates among patients with BCC after superficial radiotherapy as well as Bcl‐2 and p53 e

Loss of p53 in esophageal squamous cell

Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: Analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients

✍ Akinori Egashira; Masaru Morita; Rintaro Yoshida; Hiroshi Saeki; Eiji Oki; Noria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Mutation of p53 in head and neck squamou

Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis

✍ Genevieve A. Andrews; Sichuan Xi; Rebecca G. Pomerantz; Charles J. Lin; William 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of